Immunome (IMNM)
Develops targeted oncology drugs across ADCs, radioligands and small molecules.
$27.32
At close+0.26 (+0.94%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions208 holders · as of Mar 31, 2026 | 102.73% | 116.67M shares | |
| Insiders9 holders · as of Aug 12, 2026 | 1.49% | 1.69M shares | |
| Adds to | 104.22% |
113.58M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (113.58M in the company's Sep 3, 2026 report, 95.60M elsewhere); stakes use the report.
These groups come from separate filings that can overlap, so they add to 104.22%; nothing is left for Other.
Institutions13F, as of Mar 31, 2026
208 holders · 116.67M shares · 49 new positions · 124 increased · 48 reduced · 32 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 16.97M | 14.94% | +420.2K | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | 16.36M | 14.41% | +2.94M | May 15, 2026 |
| BlackRock, Inc. | 8.17M | 7.19% | +573.7K | May 13, 2026 |
| Redmile Group, LLC | 5.56M | 4.89% | −159.5K | May 15, 2026 |
| State Street Corp | 5.40M | 4.75% | +1.53M | May 15, 2026 |
| Primecap Management Co/CA/ | 4.79M | 4.22% | +102.8K | May 11, 2026 |
| Wellington Management Group LLP | 4.73M | 4.17% | +3.80M | May 15, 2026 |
| Vanguard Capital Management LLC | 4.43M | 3.90% | +4.43Mnew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 15.00% | 13.06M | 13G | Oct 7, 2025 ↗ |
| T. Rowe Price Investment Management, Inc. | 14.50% | 16.36M | 13G | May 15, 2026 ↗ |
| BlackRock, Inc. | 6.60% | 3.98M | Oct 22, 2024 ↗ | |
| Sirenia Capital Management LP | 6.10% | 6.90M | 13G | May 15, 2026 ↗ |
| Ein #incl. Janus Henderson Group plc | 5.80% | 3.49M | Nov 14, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 12, 2026 | Isaac Barchasdirector | Sale | 11,048 | $27.25 | 92,211 |
| Aug 11, 2026 | Isaac Barchasdirector | Sale | 62,291 | $26.23 | 0 |
| Aug 10, 2026 | Isaac Barchasdirector | Sale | 10,125 | $26.07 | 62,291 |
| Aug 7, 2026 | Isaac Barchasdirector | Sale | 15,248 | $26.06 | 72,416 |
| Aug 6, 2026 | Isaac Barchasdirector | Sale | 20,840 | $26.06 | 87,664 |
| Aug 4, 2026 | Kinney Hornofficer: CHIEF BUSINESS OFFICER | Sale | 90,616 | $25.09 | 0 |
| Jul 7, 2026 | Kinney Hornofficer: CHIEF BUSINESS OFFICER | Sale | 1,092 | $25.00 | 0 |
| Jul 2, 2026 | Robert Lechleiderofficer: Chief Medical Officer | Sale · 3 lots | 55,000 | $22.62 | 15,805 |
| Jul 7, 2026 | Isaac Barchasdirector | Sale | 16,906 | $24.20 | 108,504 |
| Jul 6, 2026 | Isaac Barchasdirector | Sale | 83,094 | $24.11 | 125,410 |
CongressHouse and Senate disclosures
Not reported.